Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia

Recombinant human activated protein C (APC), which has both anticoagulant and anti-inflammatory properties, improves survival of patients with severe sepsis. This beneficial effect is especially apparent in patients with pneumococcal pneumonia. Earlier treatment with APC in sepsis has been associate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis and haemostasis Jg. 106; H. 6; S. 1189
Hauptverfasser:	Schouten, Marcel, van 't Veer, Cornelis, Roelofs, Joris J T H, Gerlitz, Bruce, Grinnell, Brian W, Levi, Marcel, van der Poll, Tom
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Germany 01.12.2011
Schlagworte:	Animals Anti-Inflammatory Agents - administration & dosage Antithrombin III - metabolism Biomarkers - metabolism Blood Coagulation - drug effects Cytokines - metabolism Disease Models, Animal Down-Regulation Fibrin Fibrinogen Degradation Products - metabolism Humans Lung - drug effects Lung - metabolism Lung - pathology Male Mice Mice, Inbred C57BL Peptide Hydrolases - metabolism Pneumonia, Pneumococcal - blood Pneumonia, Pneumococcal - immunology Protein C - administration & dosage Recombinant Proteins - administration & dosage Streptococcus pneumoniae - growth & development Streptococcus pneumoniae - immunology Streptococcus pneumoniae - pathogenicity
ISSN:	0340-6245, 2567-689X, 2567-689X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!